KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Other financing activities: 2017-2018

Historic Other financing activities for Moderna (MRNA) over the last 2 years, with Dec 2018 value amounting to $11.6 million.

  • Moderna's Other financing activities fell 137.20% to -$3.7 million in Q4 2019 from the same period last year, while for Dec 2019 it was $9.9 million, marking a year-over-year change of. This contributed to the annual value of $11.6 million for FY2018, which is 327.13% up from last year.
  • Latest data reveals that Moderna reported Other financing activities of $11.6 million as of FY2018, which was up 327.13% from $2.7 million recorded in FY2017.
  • In the past 5 years, Moderna's Other financing activities ranged from a high of $11.6 million in FY2018 and a low of $2.7 million during FY2017.
  • Over the past 2 years, Moderna's median Other financing activities value was $7.2 million (recorded in 2017), while the average stood at $7.2 million.
  • Data for Moderna's Other financing activities shows a peak YoY skyrocketed of 327.13% (in 2018) over the last 5 years.
  • Moderna's Other financing activities (Yearly) stood at $2.7 million in 2017, then skyrocketed by 327.13% to $11.6 million in 2018.